Hegseth Orders Military Testosterone Screening: What to Know

Pentagon Announces Mandatory Testosterone Testing for Troops Over 30

U.S. Defense Secretary Pete Hegseth has announced a sweeping new policy requiring all active-duty service members aged 30 and older to undergo annual testosterone screening as part of their routine health assessments. The initiative, dubbed 'Project High-T' by Pentagon officials, aims to identify and treat low testosterone levels to optimize combat readiness. Service members under 30 may voluntarily request the test. If a deficiency is detected, troops will be offered testosterone replacement therapy (TRT) — but treatment is optional. The announcement, made via a video posted to social media on July 15, 2026, has sparked intense debate among medical professionals, lawmakers, and military personnel.

Hegseth framed the program as a readiness imperative. 'We must constantly seek new ways to optimize your performance, your resilience, and your long-term health,' he said in the video. 'This is not about artificial enhancement — it's about restoring and optimizing natural capabilities to extend your service life.' However, the Pentagon's new medical screening policy has raised significant questions about scientific validity, cost, and potential side effects.

What Is Testosterone and Why Does Hegseth Want to Test It?

Testosterone is the primary male sex hormone, responsible for muscle mass, bone density, fat distribution, red blood cell production, and libido. While naturally present in both men and women, levels are significantly higher in men. Normal testosterone ranges typically fall between 300 and 800 nanograms per deciliter (ng/dL), though these values vary by age, time of day, and individual physiology.

Hegseth's policy mandates screening for what he calls 'testosterone deficiency' — a condition often referred to as 'low T.' The Defense Secretary has long emphasized physical standards and a 'warrior ethos,' previously calling for a return to 'the highest male standard' for combat roles. Critics argue the policy is less about medical necessity and more about promoting a hyper-masculine culture within the armed forces.

Medical Experts Push Back

The medical community has reacted with near-universal skepticism. The Endocrine Society and the American Urological Association both recommend against routine testosterone screening in asymptomatic individuals. 'Testosterone levels fluctuate naturally based on sleep, stress, diet, and even time of day,' said Dr. Céline Gounder, a CBS News medical correspondent. 'A single blood test is not sufficient to diagnose deficiency.'

Dr. Bradley Anawalt, a professor of medicine at the University of Washington, told The Washington Post that 'normal testosterone values are a broad range. Someone with 700 ng/dL is not stronger or smarter than someone with 300 ng/dL.' He warned that the policy could lead to overtreatment, with healthy troops being prescribed hormones they don't need.

Risks of Testosterone Replacement Therapy

While TRT can benefit men with clinically diagnosed hypogonadism (true testosterone deficiency), it carries significant risks for those with normal levels. Common side effects include:

• Reduced sperm production and potential infertility
• Increased risk of blood clots (deep vein thrombosis and pulmonary embolism)
• Worsening of sleep apnea
• Acne, breast enlargement, and mood swings
• Long-term dependence on exogenous hormones

Experts also note that low testosterone in younger men is often a symptom of underlying issues such as chronic stress, poor sleep, overtraining, or blast exposure — not a condition requiring hormone therapy. 'Treating the root cause — like sleep apnea or nutritional deficiencies — is more effective than simply prescribing testosterone,' said a professor of kinesiology quoted by The Washington Post, who called the blanket screening 'a ridiculous idea.'

Cost and Implementation Challenges

The financial burden of the program is substantial. Each blood test costs approximately $50 to $100, and with roughly 1.3 million active-duty troops aged 30 and older, annual screening alone could cost between $65 million and $130 million. Treatment costs — including doctor visits, injections, gels, or pellets — would add hundreds of millions more if a significant fraction of troops opt for TRT. The Pentagon has not yet released a budget estimate.

Furthermore, the policy appears to conflict with FDA guidelines, which approve TRT only for men with diagnosed hypogonadism — a condition affecting about 5% of the male population. Screening millions of healthy service members for a condition most do not have is medically unprecedented.

Political and Cultural Context

The testosterone initiative is part of a broader push by the Trump administration to emphasize traditional masculinity. Hegseth has previously questioned women's roles in combat and launched a review of 'operational effectiveness of women' in the military. The administration has also courted figures from the 'manosphere' — online communities promoting macho, anti-feminist ideologies. Reports indicate the administration pressured Romania to lift travel bans against Andrew Tate, a controversial influencer and self-proclaimed 'king of toxic masculinity.'

Critics see the testosterone policy as an extension of this agenda. 'This is not about readiness — it's about ideology,' said a senior Democratic senator on the Armed Services Committee, speaking on condition of anonymity. 'We should be investing in sleep, nutrition, and mental health, not pushing hormones on healthy young people.'

The controversy over military medical standards echoes earlier debates about transgender troops and physical fitness requirements. Hegseth's push for testosterone screening may face legal challenges if service members argue it violates medical privacy or constitutes a form of discrimination.

What Happens Next?

The Pentagon has not announced a timeline for implementation. The policy will likely require rulemaking, medical guideline updates, and potentially congressional approval for funding. Service members' advocacy groups are calling for transparency and independent medical review.

For now, the military medical community is preparing for a flood of tests and consultations. 'We're going to see a lot of healthy people with normal hormone levels being told they might need treatment,' said one military doctor who spoke on condition of anonymity. 'That's not good medicine.'

Frequently Asked Questions

Is testosterone screening mandatory for all troops?

Yes, for active-duty service members aged 30 and older, annual screening will be part of their periodic health assessment. Troops under 30 may request a test voluntarily. However, any treatment recommended as a result is optional.

What are normal testosterone levels?

Normal total testosterone levels typically range from 300 to 800 ng/dL, though this varies by laboratory and individual factors. Levels below 300 ng/dL may indicate deficiency, but diagnosis requires multiple tests and clinical symptoms.

Can women be affected by this policy?

Yes, the policy applies to all service members regardless of gender. Women naturally have lower testosterone levels, and experts worry that applying male-centric standards could lead to unnecessary treatment.

What are the alternatives to TRT?

For men with mildly low testosterone, lifestyle changes — including improved sleep, stress management, resistance training, and a balanced diet — can often raise levels naturally. Treating underlying conditions like sleep apnea or obesity is also recommended before considering hormone therapy.

When will the policy take effect?

The Pentagon has not provided an implementation date. The policy must undergo internal review, and potential legal challenges could delay or alter its rollout.

Sources

Military.com: Hegseth Orders Mandatory Testosterone Screening
The Guardian: US Military to Offer Testosterone Screening
CBS News: Hegseth Military Testosterone Plan Risks and Benefits
The Washington Post: Hegseth Touts High Testosterone; Doctors Question Claims